BE829058A - Medicament ayant un effet psychotrope, a base de derive de l'pyroglutamyle - Google Patents

Medicament ayant un effet psychotrope, a base de derive de l'pyroglutamyle

Info

Publication number
BE829058A
BE829058A BE156336A BE156336A BE829058A BE 829058 A BE829058 A BE 829058A BE 156336 A BE156336 A BE 156336A BE 156336 A BE156336 A BE 156336A BE 829058 A BE829058 A BE 829058A
Authority
BE
Belgium
Prior art keywords
pyroglutamyl
derivatives
medicinal product
psychotropic effect
psychotropic
Prior art date
Application number
BE156336A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE829058A publication Critical patent/BE829058A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • C07K5/06173Dipeptides with the first amino acid being heterocyclic and Glp-amino acid; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/282-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
BE156336A 1974-05-14 1975-05-14 Medicament ayant un effet psychotrope, a base de derive de l'pyroglutamyle BE829058A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2423389A DE2423389A1 (de) 1974-05-14 1974-05-14 Arzneimittel mit psychotroper wirkung und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
BE829058A true BE829058A (fr) 1975-11-14

Family

ID=5915522

Family Applications (1)

Application Number Title Priority Date Filing Date
BE156336A BE829058A (fr) 1974-05-14 1975-05-14 Medicament ayant un effet psychotrope, a base de derive de l'pyroglutamyle

Country Status (11)

Country Link
US (1) US4053588A (https=)
JP (1) JPS50157361A (https=)
BE (1) BE829058A (https=)
CA (1) CA1067410A (https=)
DE (1) DE2423389A1 (https=)
DK (1) DK207575A (https=)
FR (1) FR2270867B1 (https=)
GB (1) GB1503680A (https=)
IE (1) IE41055B1 (https=)
LU (1) LU72449A1 (https=)
NL (1) NL7505479A (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1492640A (en) * 1975-07-08 1977-11-23 Ucb Sa L-pyroglutamyl-l-prolinamide
US4868156A (en) * 1986-02-28 1989-09-19 Bio-Tech A/S Pharmaceutical preparation containing a dipeptide with cell growth regulating effect
IT1244548B (it) * 1991-02-06 1994-07-15 Poli Ind Chimica Spa Derivati della 5-oxo-l-prolina e loro applicazioni farmaceutiche
BRPI0413558A (pt) 2003-08-12 2006-10-17 3M Innovative Properties Co compostos contendo imidazo substituìdo por hidroxilamina
MXPA06002199A (es) 2003-08-27 2006-05-22 3M Innovative Properties Co Imidazoquinolinas sustituidas con grupos ariloxi o arilalquilenoxi.
CA2537763A1 (en) 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for cd5+ b cell lymphoma
CA2540541C (en) 2003-10-03 2012-03-27 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
US7897767B2 (en) 2003-11-14 2011-03-01 3M Innovative Properties Company Oxime substituted imidazoquinolines
WO2005048945A2 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Hydroxylamine substituted imidazo ring compounds
WO2005051317A2 (en) 2003-11-25 2005-06-09 3M Innovative Properties Company Substituted imidazo ring systems and methods
JP2007517035A (ja) 2003-12-29 2007-06-28 スリーエム イノベイティブ プロパティズ カンパニー アリールアルケニルおよびアリールアルキニル置換されたイミダゾキノリン
EP1699788A2 (en) 2003-12-30 2006-09-13 3M Innovative Properties Company Imidazoquinolinyl, imidazopyridinyl and imidazonaphthyridinyl sulfonamides
WO2005094531A2 (en) 2004-03-24 2005-10-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
US8017779B2 (en) 2004-06-15 2011-09-13 3M Innovative Properties Company Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
US7897609B2 (en) 2004-06-18 2011-03-01 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
US8026366B2 (en) 2004-06-18 2011-09-27 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
US7915281B2 (en) 2004-06-18 2011-03-29 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
AU2005326708C1 (en) 2004-12-30 2012-08-30 3M Innovative Properties Company Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
JP5543068B2 (ja) 2004-12-30 2014-07-09 スリーエム イノベイティブ プロパティズ カンパニー キラル縮合[1,2]イミダゾ[4,5−c]環状化合物
JP2008526757A (ja) * 2004-12-30 2008-07-24 スリーエム イノベイティブ プロパティズ カンパニー 免疫応答調節剤製剤および方法
WO2006084251A2 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune reponse modifiers
CA2597587A1 (en) 2005-02-11 2006-08-17 Coley Pharmaceutical Group, Inc. Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
JP2008538550A (ja) 2005-04-01 2008-10-30 コーリー ファーマシューティカル グループ,インコーポレイテッド ウイルス感染および腫瘍性疾患を処置するためのサイトカイン生合成の調節因子としての1−置換ピラゾロ(3,4−c)環状化合物
JP2008535832A (ja) 2005-04-01 2008-09-04 コーリー ファーマシューティカル グループ,インコーポレイテッド ピラゾロピリジン−1,4−ジアミン、およびそのアナログ
US7906506B2 (en) 2006-07-12 2011-03-15 3M Innovative Properties Company Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
DE102014110783B4 (de) * 2014-07-30 2025-12-24 Licit Solutions Gmbh Zusammensetzung zur Konservierung und Fixierung von Organen, Geweben, Ganzkör-perpräparaten und Leichen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE63496C (de) * B. A. DOBSON in Bolton, Grafsch. Lancaster, England, und E. APPENZELLER in Alost, Belgien Krempel mit Verringerung der Geschwindigkeit des Abnehmers beim Zerreifsen des Bandes
US3002978A (en) * 1958-05-06 1961-10-03 Bocher Gustave Marie Joseph Glyceryl pyrrolidone carboxylates
FR2207707A1 (en) * 1972-11-27 1974-06-21 Fabre Sa Pierre 2-Pyrrolidone-5-carboxylic acid esters and amides - with sedative and hypnotic activity

Also Published As

Publication number Publication date
IE41055B1 (en) 1979-10-10
FR2270867B1 (https=) 1978-08-04
JPS50157361A (https=) 1975-12-19
NL7505479A (nl) 1975-11-18
LU72449A1 (https=) 1977-02-09
DE2423389A1 (de) 1975-12-04
DK207575A (da) 1975-11-15
US4053588A (en) 1977-10-11
FR2270867A1 (https=) 1975-12-12
IE41055L (en) 1975-11-14
GB1503680A (en) 1978-03-15
CA1067410A (en) 1979-12-04

Similar Documents

Publication Publication Date Title
BE829058A (fr) Medicament ayant un effet psychotrope, a base de derive de l'pyroglutamyle
BE854270A (fr) Medicament anti-tumeur a base de compose du type lysolecithine
PH11040A (en) 1,1-diamino ethylene derivatives and a pharmaceutical composition thereof
BE839632A (fr) Medicament a base de sulfadiazine zincique
BE883495A (fr) Medicament hypolipemiqude a base de carnitine
BE854925A (fr) Acides 12-azaprostanoiques utiles comme medicament
BE866276A (fr) Composes a cycle beta-lactame, utilisables comme medicament
PH11669A (en) Thienobenzo(1,5)diazepine derivatives and the pharmaceutical formulation thereof
BE854072A (fr) Nouvelles aminopiperidines, leur preparation et leur emploi comme medicament
BE827595A (fr) Medicament a administration par voie orale produisant un effet inhibiteur de l'antiplasmine
BE844532A (fr) Medicament a base d'un derive du benzothiadiazole
FR2307541A1 (fr) Medicament a base d'un polypeptide
BE767707A (fr) Medicament a base d'un derive de l'aminoacetonitrile
FR2342067A1 (fr) Medicament a base d'un derive de la quinoleine
BE802995A (fr) Medicament a base d'un derive de l'oxindole
BE865369A (fr) Medicament a base d'extrait de physarym
BE811547A (fr) Medicament a base d'un derive de la 7h-benzocycloheptene-7-one
AU473590B2 (en) New 1, 4-dihydroquinoline derivatives, theer production, and their medicinal use
BE801014A (fr) Medicament a base d'(hydroxy-2 indanyl-2)1 propylamine
BE771112A (fr) Medicament a base d'un derive de l'aminoguanidine
BE770844A (fr) Medicament a base d'un derive de diphenyl-alcane
FR2282907A1 (fr) Nouvel amide tetrapeptidique, utile comme medicament
IL45655A0 (en) New n'-(aminoacylaminophenyl)-acetamidenes and salts thereof,their production and their medicinal use
PH12316A (en) 5"-amino-4',5"-dideoxyambutyrosin a and salts thereof
BE806158A (fr) Medicament a base d'ergocornine ou de 2-bromo-alpha-ergokryptine